• 검색 결과가 없습니다.

Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence

N/A
N/A
Protected

Academic year: 2021

Share "Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence"

Copied!
12
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Summarized table of clinical characteristics
Figure 1. Mutation landscape represented by top 20 frequently mutated genes (SNV + InDels) in 87 samplesfrom 31 patients
Figure 3. Mutated allele frequency of KMT2C c.5053G>T in 7 patients at different timepoints

참조

관련 문서

Method We obtained blood samples from 49 patients who underwent surgical treatment for esophageal squamous cell cancer (ESCC) We performed ctDNA analysis with

Analysing this research material, The present study were examined that extravasated blood and cancer had interrelationship by comparing cancer patients

The aim of this study was to provide a optimal drug therapy which secures effectiveness and safeness in elderly patients by analyzing polypharmacy and the

In this study, to investigate how applying a critical pathway to stomach cancer patients affects their recovery and treatment, the clinical effect of the critical

Kameoka, “Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green,” World Journal of Surgical Oncology, Vol..

A retrospective analysis of invasive tumor percentages of GSS tumor samples showed that samples with high tumor content correlated well with FNAB samples

To assess the clinical usefulness of performing Q-PCR in practice as a diagnostic technique, we compared blindly the Q-PCR results using blood samples of the

This study’s TCHP group lost both muscle and fat, whereas the AC-T group had no signif- icant change in muscle but gained fat, which suggests that the type of chemotherapy